Skip to main content
. Author manuscript; available in PMC: 2023 Oct 1.
Published in final edited form as: J Pediatr. 2022 Jun 27;249:59–66.e1. doi: 10.1016/j.jpeds.2022.06.023

Table II.

Spina bifida cases by lesion level, pregnancy outcome, and fortification period

Lesion level Total cases
Prefortification period
Postfortification period
LB SB NLB Total % of total cases LB SB NLB Total % of total cases LB SB NLB Total % of total cases
Upper* 249 17 52 318 12.3 104 6 31 141 24.6 145 11 21 177 8.8
 Cervical 25 6 7 38 1.5 7 5 13 2.3 18 5 25 1.2
 Thoracic 221 10 45 276 10.6 97 5 26 128 22.3 124 5 19 148 7.3
Lower* 1718 110 279 2109 81.3 305 25 70 400 69.8 1413 85 209 1709 84.6
 Lumbar 1498 75 231 1806 69.6 270 17 65 352 61.4 1228 58 166 1454 72.0
 Sacral 211 32 42 285 11.0 32 7 5 44 7.7 179 25 37 241 11.9
Total 2080 156 355 2593 429 36 108 573 1651 120 247 2020

LB, live births; NLB, terminations and other nonlive births (including pregnancy losses before 20 wk of gestation); SB, stillbirths (pregnancy losses at 20 or more wk of gestation).

*

Upper lesion level cases include cervical, thoracic, and upper not otherwise specified (NOS). Upper NOS contributed to <0.2% of upper-level cases. Lower lesion level cases include lumbar, sacral, and lower NOS. Lower NOS contributed to <0.7% of lower-level cases.

Total includes lesion level NOS and unknown/missing.